Evan Gibson is the vice president of corporate development at Neumora. Previously, Evan was senior director and head of corporate development at Vir Biotechnology, where he helped build the company through business development and contributions to strategy and operational functions.
Prior to Vir, Evan gained broad commercial experience across multiple functions at Genentech, including roles in marketing, where he supported the FDA approval and commercial launch of a small molecule oncology product, pricing and payer contracting, and sales. Evan spent his early career in the Healthcare Investment Banking Group at JMP Securities, where he executed transactions generating more than $2 billion in financing proceeds for life sciences companies and multiple acquisitions and strategic advisory assignments.
Evan holds a B.A. in economics from Yale University, an MBA in healthcare management from The Wharton School, and a Master of biotechnology from the School of Engineering and Applied Sciences at the University of Pennsylvania.